Home › Funds › CRAMER ROSENTHAL MCGLYNN LLC › TECH

CRAMER ROSENTHAL MCGLYNN LLC position in TECH

BIO-TECHNE CORP · Health Care

CRAMER ROSENTHAL MCGLYNN LLC reported holding 774,723 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$54.7M, representing 2.83% of its reported portfolio and ranking #7 among its reported holdings. CRAMER ROSENTHAL MCGLYNN LLC has disclosed TECH holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)774.72K sh
Reported value held$54.73M
Portfolio Weight2.83%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CRAMER ROSENTHAL MCGLYNN LLC's TECH position evolved

CRAMER ROSENTHAL MCGLYNN LLC first disclosed a stake in TECH in Q4 2023 at 233,274 shares (US$18.0M). The position peaked in Q2 2026 at 774,723 shares, worth US$54.7M. Across 11 filings, CRAMER ROSENTHAL MCGLYNN LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 774,723 shares valued at US$54.7M — an increase of 339,090 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2024 (shares rose 2% over the following quarter), a 33% trim in Q1 2026 (shares rose 35% over the following quarter), a 78% increase in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 233.27K $18.00M New
Q1 2024 380.80K $26.80M Add
Q2 2024 373.02K $26.73M Reduce
Q3 2024 496.81K $39.71M Add
Q4 2024 485.52K $34.97M Reduce
Q1 2025 563.73K $33.05M Add
Q2 2025 521.99K $26.86M Reduce
Q3 2025 559.19K $31.11M Add
Q4 2025 654.47K $38.49M Add
Q1 2026 435.63K $22.77M Reduce
Q2 2026 774.72K $54.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has CRAMER ROSENTHAL MCGLYNN LLC held TECH?

CRAMER ROSENTHAL MCGLYNN LLC has disclosed TECH holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is CRAMER ROSENTHAL MCGLYNN LLC's current position in TECH?

As of Q2 2026, CRAMER ROSENTHAL MCGLYNN LLC holds 774.72K shares of TECH (BIO-TECHNE CORP), valued at $54.73M, representing 2.83% of its reported portfolio and ranking #7.

Has CRAMER ROSENTHAL MCGLYNN LLC been buying or selling TECH?

In the latest 13F filing (Q2 2026), CRAMER ROSENTHAL MCGLYNN LLC increased its position in TECH. The position peaked in Q2 2026 at 774.72K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.